Skip to Content

STADA Arzneimittel AG STDAF

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Stada Arzneimittel is a specialty and generic drug manufacturing company. The vast majority of the company's sales are derived from its generic drug products, followed by its branded products. Most of the company's generic sales take place in Germany, followed by Italy and Spain. Germany also leads the branded products segment, followed by the United Kingdom and Russia. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Stadastrase 2-18
Bad Vilbel, HE, 61118, Germany
T +49 61016030
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2019
Fiscal Year End Dec 31, 2021
Stock Type
Employees 12,471